NEW YORK, Dec. 14 — X-ray system developer Bruker AXS earned $53 million after filing an initial public offering on Friday that let loose 9 million shares of common stock at a cost of $6.50 apiece, the company announced on Friday. Shares of the Madison, Wis.-based firm began trading on the Nasdaq on Friday under the ticker symbol BAXS, trading at $6.75 just after 11:00 a.m.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.